Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Articles

173287 items
12:15 PM, Sep 14, 2018  |  BC Week In Review | Clinical News  |  Clinical Results

Novocure planning submission for TTFields in mesothelioma

Novocure Ltd. (NASDAQ:NVCR) reported final data from the Phase II STELLAR trial to treat previously untreated unresectable malignant pleural mesothelioma showing that its Tumor Treating Fields (TTFields) plus standard of care (SOC) chemotherapy significantly improved...
10:29 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Xenon further strengthens balance sheet with $63M follow-on

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel. The price is a 2% discount to Xenon's closing price of $14.25...
10:29 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Neurological organoid company System1 raises $25M in series A

System1 Biosciences Inc. (San Francisco, Calif.) raised $25 million in a series A round co-led by CRV and Pfizer Ventures. Alexandria Venture Investments, Dolby Family Ventures, Longevity Fund, Riot Ventures, Kinled Holding, Wilmot Ventures, Webb...
10:29 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Epic raises $52M series E

Epic Sciences Inc. (San Diego, Calif.) raised $52 million in a series E round led by Blue Ox Healthcare Partners. Fellow new investors Deerfield Management and Varian Medical Systems Inc. (NYSE:VAR) joined existing investors Altos...
10:28 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

MPM, Versant launch gene therapy play Coda

Coda Biotherapeutics Inc. (South San Francisco, Calif.) debuted with a $19 million series A round led by seed investors MPM Capital and Versant Ventures. New investors Astellas Venture Management and Novartis AG (NYSE:NVS; SIX:NOVN) also...
10:28 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Sorrento subsidiary raises $140M to launch pain patch

Scilex Pharmaceuticals Inc. (San Diego, Calif.), a majority-owned subsidiary of Sorrento Therapeutics Inc. (NASDAQ:SRNE), raised $140 million on Sept. 7 through a debt financing from Morgan Stanley. The company said the proceeds will go towards...
10:28 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Sales & Marketing

ICER finds opioid use disorder treatments not cost-effective

In a draft evidence report, ICER found that newer extended-release formulations of medication-assisted treatments (MATs) for opioid use disorder were not cost-effective compared with generic medicines. The institute compared the clinical effectiveness and value of three...
10:27 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Takeda to move U.S. headquarters to Boston area

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half. Takeda spokesperson...
10:27 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Deals

Boehringer to acquire oncolytic virus company ViraTherapeutics

Boehringer Ingelheim GmbH (Ingelheim, Germany) exercised an option to acquire oncolytic virus company ViraTherapeutics GmbH (Innsbruck, Austria). Boehringer gained the option under a 2016 deal to jointly develop ViraTherapeutics' oncolytic virus therapy platform and its...
10:27 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Deals

Zai Lab gets Chinese rights to Novocure's oncology tech

Novocure Ltd. (NASDAQ:NVCR) granted Zai Lab Ltd. (NASDAQ:ZLAB) exclusive rights to oncology platform Tumor Treating Fields in China, including Hong Kong and Macau, and Taiwan. Novocure will receive $15 million up front and is eligible for...

Pages